Cure Today20h
FDA Grants BTD to the ADC GSK’227 in Relapsed/Refractory Osteosarcoma
The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...
GSK Nears $1 Billion Deal for Biotech Company IDRx
GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British ...
Hosted on MSN2d
FDA awards GSK breakthrough status for relapsed osteosarcoma treatment
"FDA awards GSK breakthrough status for relapsed osteosarcoma treatment" was originally created and published by ...
The Pharma Letter3d
BRIEF—FDA Breakthrough status for GSK’227 in osteosarcoma
UK pharma major GSK today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for GSK5764227 (GSK’227), its B7-H3-targeted antibody-drug conjugate ...
Daily3d
GSK bone cancer treatment gets USFDA Breakthrough Therapy Designation
London: GSK plc has announced that the US Food and Drug Administration (USFDA) has granted Breakthrough Therapy Designation ...
GSK cancer drug candidate gets another breakthrough designation
GSK announced on Tuesday that its investigational antibody-drug conjugate GSK'227 has been granted breakthrough therapy ...
Why Viking Therapeutics Stock Plummeted by 24% in December
Viking Therapeutics ( VKTX -2.05%) didn't exactly capture investors' hearts in the final month of 2024. The biotech company's ...
Health Care Roundup: Market Talk
Find insight on China’s healthcare sector, Wuxi Biologics and more in the latest Market Talks covering the Health Care sector ...
Businessworld13d
kalyan chart din ka
INR:0630. kalyan chart din ka Hansoh Pharmaceuticals' "Emifenamide Tenofovir Tablets" is expected to be reviewed for priority in its application for listing 4 ...